Table 2.
Prevalence of comorbidities in the study cohort (n = 2137).
| Comorbidity | Number (%) |
|---|---|
| Hypertension | 1204 (56.3) |
| Gastrointestinal disorders | 985 (46.1) |
| Hyperlipidemia | 915 (42.8) |
| Psychiatric disorders | 516 (24.1) |
| Asthma | 406 (19.0) |
| Hyperuricemia | 377 (17.6) |
| Coronary artery disease | 363 (17.0) |
| Osteoporosis | 340 (15.9) |
| Diabetes | 276 (12.9) |
| Sleep apnea | 228 (10.7) |
| Heart failure | 110 (5.1) |
The table shows absolute numbers and percentages. Comorbidities were assessed by structured interviews based on patients’ reports of physician-based diagnoses. For all comorbidities except cardiac failure and sleep apnea, the presence of disease-specific medication was additionally taken into account.